Unity Biotechnology, Inc.

UBXCIK 0001463361 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 11, 2025. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0006

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Sep 26, 2025no items parsed Sep 19, 2025no items parsed Jul 24, 2025no items parsed Jul 22, 2025no items parsed Jun 30, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Unity Biotechnology, Inc.

Name	Roles	Filings
Ghosh Anirvan	OfficerDirector	30
Nguyen Alexander Hieu	Officer	10
Dananberg Jamie	Officer	9
Sullivan Lynne Marie	Officer	9
Samar Michael P.	Director	4

Showing 1-5 of 13

Per pagePage 1 of 3Next

All filings

82 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Nov 6, 2024	Nguyen Alexander Hieu Chief Legal Officer	SSale	149	$1.29	$192

Filed		Top transaction	Shares	Price	Value